跳至主要内容
临床试验/JPRN-UMIN000021948
JPRN-UMIN000021948已完成未知

Randomized control study for the effectiveness of tenofovir in nucleoside/nucleotide analogue-treated patients with chronic HBV infection - Tenofovir study in NA-treated patients with HBV

Tohoku University0 个研究点目标入组 180 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who is received interferon treatments (2) Patients who is taking immunosuppressive agents (3) Patients who have present or past hepatocellular carcinoma, or other malignant diseases (4) Patients who have decompensated liver cirrhosis (5) Patients who have renal dysfunction (eGFR is less than 50 ml/min/1.72m2) (6) Patients who have low serum phosphorus (less than 2.5 mg/dl) (7) Patients who are pregnant or have possibility of pregnancy (8) Breast-feeding patients (9) Patients who is infected also with HIV or HCV (10) Patients who is participating other studies (11) Patients who is considered inappropriate for this study by doctors in attendance

研究者

相似试验